Codexis (CDXS) Amortizatization of Intangibles (2010 - 2015)
Codexis (CDXS) posted quarterly Amortizatization of Intangibles of $1000.0 for Q2 2015, up 200.0% year-over-year from $333.33 in Q2 2014, and up 200.0% quarter-over-quarter from -$1000.0 in Q1 2015.
Codexis (CDXS) Amortizatization of Intangibles (2010 - 2015) Analysis & Trends
Codexis' Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $1000.0 for Q2 2015.
- In Q2 2015, Amortizatization of Intangibles rose 200.0% year-over-year to $1000.0; the TTM figure through Mar 2016 stood at $1000.0 (up 150.0% YoY), while the FY2014 annual figure was -$2000.0, up 98.18% from the prior year.
- Amortizatization of Intangibles for Q2 2015 stood at $1000.0, up from -$1000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $43000.0 in Q1 2013, with the low at -$798000.0 in Q4 2011.
- The 5-year median for Amortizatization of Intangibles is $6000.0 (2012), against an average of -$53312.5.
- Peak annual rise in Amortizatization of Intangibles reached 514.29% in 2013, while the deepest fall reached 2262.5% in 2013.
- Codexis' Amortizatization of Intangibles stood at -$798000.0 in 2011, then jumped by 101.0% to $8000.0 in 2012, then tumbled by 2262.5% to -$173000.0 in 2013, then jumped by 99.42% to -$1000.0 in 2014, then surged by 200.0% to $1000.0 in 2015.
- Business Quant data shows CDXS's Amortizatization of Intangibles at $1000.0 in Q2 2015, -$1000.0 in Q1 2015, and -$1000.0 in Q2 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | 947,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 1,000.00 |
| Jun 30, 2015 | 1,000.00 |
| Mar 31, 2015 | -1,000.00 |
| Mar 31, 2015 | -1,000.00 |
| Jun 30, 2014 | -1,000.00 |
| Jun 30, 2014 | -1,000.00 |
| Mar 31, 2014 | -1,000.00 |
| Mar 31, 2014 | -1,000.00 |
| Dec 31, 2013 | -173,000.00 |
| Dec 31, 2013 | -173,000.00 |
| Sep 30, 2013 | 15,000.00 |
| Sep 30, 2013 | 15,000.00 |
| Jun 30, 2013 | 5,000.00 |
| Jun 30, 2013 | 5,000.00 |
| Mar 31, 2013 | 43,000.00 |
| Mar 31, 2013 | 43,000.00 |
| Dec 31, 2012 | 8,000.00 |
| Dec 31, 2012 | 8,000.00 |
| Sep 30, 2012 | 7,000.00 |
| Sep 30, 2012 | 7,000.00 |